China’s internet companies reported resilient 3Q25 top-line growth and continuous margin improvement in the online gaming and OTA sectors, empowered by improved AI efficiency and benign competition. Margin pressure in e-commerce due to the intense on-demand delivery competition is likely to ease in 4Q25, but could persist into 2026 given the continuous investment and tough comparison base boosted by the trade-in programme in 2025. Maintain MARKET WEIGHT. Top BUYs: Alibaba, Tencent, TCOM, TME, Ne...
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in November 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on ...
Highlights We expect global liquidity cycle to remain strong for at least 1H26, following the Fed’s return to policy easing in Sep 25, benefitting emerging market assets and commodities. Chinese equities are likely to rally further, and our index target for MSCI China index target is at 104 pts based on 16.3x 12-month forward PE and 6% EPS growth assumption. We prefer exposure to growth industries like AI/semiconductors, automation/robotics, ADAS and innovative drugs and liquidity proxies ...
In today's Morning Views publication we comment on developments of the following high yield issuers: Applus, Verisure, CeramTec, Kiloutou, Odido, Eolo, Flora Food Group, Altice France (SFR), evoke, FiberCop, Tele Columbus, Engineering Group, Altice International, Intralot, Mehilainen, Itelyum Group, Voyage Care, Grupo Antolin, Benteler International, Neopharmed, Cheplapharm, Industria Macchine Automatiche, Allwyn (formerly Sazka), Victoria, Best Secret, Softbank Group, Profine, Bombardier, Grune...
What’s new: Alibaba’s reported FY2Q26 revs that were above consensus and largely in line with our expectations. Cloud rev growth momentum could continue in the CY4Q25 as demand continues to outpace supply of compute. Quick commerce could also meaningfully narrow losses sequentially partly driven by further improvement in unit economics. We maintain our PT at USD200. Analysts: Jin Yoon
Alibaba reported solid 2QFY26 results. Revenue grew 5% yoy to Rmb247.8b (15% like-for-like basis), in line with the street’s estimate. Non-GAAP net profit was Rmb10.4b, down 72% yoy, missing our forecast, due to its investment in Taobao Instant Commerce. In 3QFY26, management expects: a) significant narrowing of quick commerce losses, b) moderated CMR growth due to the high base last year, and c) continued strong cloud revenue growth. Maintain BUY with a higher target price of HK$206.00 (US$206....
Top Stories Company Results | Alibaba Group (9988 HK/BUY/HK$157.80/Target: HK$206.00) Alibaba reported solid 2QFY26 results. Revenue grew 5% yoy to Rmb247.8b (15% like-for-like basis), in line with the street’s estimate. Non-GAAP net profit was Rmb10.4b, down 72% yoy, missing our forecast, due to its investment in Taobao Instant Commerce. In 3QFY26, management expects: a) significant narrowing of quick commerce losses, b) moderated CMR growth due to the high base last year, and c) continued str...
Greater China Company Results | Alibaba Group (9988 HK/BUY/HK$157.80/Target: HK$206.00) Alibaba reported solid 2QFY26 results. Revenue grew 5% yoy to Rmb247.8b (15% like-for-like basis), in line with the street’s estimate. Non-GAAP net profit was Rmb10.4b, down 72% yoy, missing our forecast, due to its investment in Taobao Instant Commerce. In 3QFY26, management expects: a) significant narrowing of quick commerce losses, b) moderated CMR growth due to the high base last year, and c) continued st...
In today's Morning Views publication we comment on developments of the following high yield issuers: Sunrise, Bite, TK Elevator, Italmatch Chemicals, Nimlas, Lowell, Intralot, Recordati, Klockner Pentaplast, Standard Profil, Advanz Pharma, Softbank Group, Ineos
In our latest Asia Monthly, we discuss the performance of major Asian credit indices and review UST curve movements in October 2025. We also provide a recap of major news and macroeconomic releases, including those from the US, China, India, Indonesia and Japan. In addition, we summarise the top/bottom performers, recent USD bond issuances and rating actions in Asian corporate credit, as well as a list of our recent research. The Asia Monthly publication serves to keep investors updated on d...
Data from the initial phase of the 11.11 campaign set a compelling prelude for a mid-single-digit GMV growth in 4Q25. The new phase of 11.11 is characterised by a longer cycle, simplified promotion mechanics, and deeper technological integration. Platform competition has shifted from “traffic wars” to “efficiency wars”, as AI enhances demand-supply matching and instant retail breaks offline barriers, reducing consumer decision costs. Maintain OVERWEIGHT. Our top picks are Alibaba and Kuaishou.
Have you missed it? As the Japanese stock market knocked unsuccessfully on the door of 50,000 yesterday [21 Oct], sentiment shifted from FOMO [fear of missing out] to FOTI [fear of topping in]. Would someone buying the Japanese market today be making the same mistake as someone buying in Oct 1989? Pelham Smithers discusses.
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.